EPISODE · Oct 27, 2020 · 15 MIN
Coagulopathies and COVID-19: Nahla Heikal, M.D.
from Answers from the Lab · host Mayo Clinic Laboratories
Speaker 1: (00:39) Can you start by sharing a little bit about yourself and your expertise for our listeners? Speaker 1: (01:12) We're in this pandemic with COVID-19, and I'm hearing about people having hematologic responses to COVID-19. Can you tell us a little bit about what these responses are? Speaker 2: (04:53) Here at Mayo Clinic, do we have an assay or a testing profile that could assist physicians who are dealing with COVID-19 and their patients and help them look at how their patients are doing? Speaker 2: (07:09) Why is this testing important and would it affect COVID-19 patient management? Speaker 2: (08:49) What challenges have you encountered during this pandemic and how have you overcome them? Speaker 2: (10:04) Is there anything you've seen that you found has been particularly inspiring during the pandemic? Speaker 2: (12:18) Is there anything else that you'd like to share with our audience?
What this episode covers
Nahla Heikal, M.D., a clinical pathologist in Mayo Clinic's Department of Laboratory Medicine and Pathology who specializes in coagulation testing, joins the "Answers From the Lab" podcast to discuss the role of coagulopathies in COVID-19, including conditions such as thrombosis and disseminated intravascular coagulation.
NOW PLAYING
Coagulopathies and COVID-19: Nahla Heikal, M.D.
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m